Cargando…
Discovery and Characterization of a Novel Cyclic Peptide That Effectively Inhibits Ephrin Binding to the EphA4 Receptor and Displays Anti-Angiogenesis Activity
The EphA4 receptor tyrosine kinase regulates a variety of physiological and pathological processes during neural development and the formation of tumor blood vessels; thus, it represents a new and promising therapeutic target. We used a combination of phage peptide display and computer modeling/dock...
Autores principales: | Han, Xiaofeng, Xu, Yan, Yang, Yilei, Xi, Jingle, Tian, Wang, Duggineni, Srinivas, Huang, Ziwei, An, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3827205/ https://www.ncbi.nlm.nih.gov/pubmed/24265799 http://dx.doi.org/10.1371/journal.pone.0080183 |
Ejemplares similares
-
Ephrin Receptors (Eph): EphA1, EphA5, and EphA7 Expression in Uveal Melanoma—Associations with Clinical Parameters and Patient Survival
por: Gajdzis, Malgorzata, et al.
Publicado: (2020) -
Theoretical Model of EphA2-Ephrin A1 Inhibition
por: Jedwabny, Wiktoria, et al.
Publicado: (2018) -
Roles of EphA1/A2 and ephrin‐A1 in cancer
por: Ieguchi, Katsuaki, et al.
Publicado: (2019) -
Effects of altered ephrin-A5 and EphA4/EphA7 expression on tumor growth in a medulloblastoma mouse model
por: Bhatia, Shilpa, et al.
Publicado: (2015) -
Inhibition of angiogenesis by leflunomide via targeting the soluble ephrin-A1/EphA2 system in bladder cancer
por: Chu, Maolin, et al.
Publicado: (2018)